Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 22431808)

1.

Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS.

Ford N, Singh K, Cooke GS, Mills EJ, von Schoen-Angerer T, Kamarulzaman A, du Cros P.

Clin Infect Dis. 2012 May;54(10):1465-72. doi: 10.1093/cid/cis227. Epub 2012 Mar 19. Review.

2.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
3.

Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas.

Lemoine M, Thursz M.

Semin Liver Dis. 2014 Feb;34(1):89-97. doi: 10.1055/s-0034-1371082. Epub 2014 Apr 29. Review.

PMID:
24782262
4.

Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.

Easterbrook P, Sands A, Harmanci H.

Semin Liver Dis. 2012 May;32(2):147-57. doi: 10.1055/s-0032-1316476. Epub 2012 Jul 3. Review.

PMID:
22760654
5.
6.

Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings.

Cleary S.

Curr Opin HIV AIDS. 2010 May;5(3):210-4. doi: 10.1097/COH.0b013e3283384a6f. Review.

PMID:
20539076
7.

HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.

Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S.

Int J Drug Policy. 2007 Oct;18(5):426-32. Epub 2007 Feb 15.

PMID:
17854732
8.

Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa.

Cooper CL, Mills E, Wabwire BO, Ford N, Olupot-Olupot P.

Int J Infect Dis. 2009 May;13(3):302-6. doi: 10.1016/j.ijid.2008.06.042. Epub 2008 Nov 11.

9.

Promoting HCV treatment completion for prison inmates: New York State's hepatitis C continuity program.

Klein SJ, Wright LN, Birkhead GS, Mojica BA, Klopf LC, Klein LA, Tanner EL, Feldman IS, Fraley EJ.

Public Health Rep. 2007;122 Suppl 2:83-8.

10.

HCV transmission in industrialized countries and resource-constrained areas.

Thursz M, Fontanet A.

Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):28-35. doi: 10.1038/nrgastro.2013.179. Epub 2013 Oct 1. Review.

PMID:
24080775
11.

Management of HIV and hepatitis B or C co-infection in 15 HIV treatment centres. Disparity between protocols and practice.

Brook MG, Jones K, Dale AW, Miller RF.

Int J STD AIDS. 2003 Jul;14(7):469-72.

PMID:
12869227
12.

Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection.

Dieterich DT.

Am J Med. 1999 Dec 27;107(6B):79S-84S.

PMID:
10653464
13.

Priority strategies for sustainable fight against HIV/AIDS in low-income countries.

Dionisio D, Esperti F, Messeri D, Vivarelli A.

Curr HIV Res. 2004 Oct;2(4):377-93. Review.

PMID:
15544458
14.

Access to antiretroviral treatment in developing countries: Which financing strategies are possible?

Beaulière A, Le Maux A, Trehin C, Perez F.

Rev Epidemiol Sante Publique. 2010 Jun;58(3):171-9. doi: 10.1016/j.respe.2010.03.002. Epub 2010 Apr 28. Review.

PMID:
20430553
16.

The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.

Rance J, Newland J, Hopwood M, Treloar C.

Soc Sci Med. 2012 Jan;74(2):245-53. doi: 10.1016/j.socscimed.2011.10.003. Epub 2011 Nov 20.

PMID:
22133583
17.

Therapy of chronic hepatitis C virus infection in HIV co-infected people.

Fabris P, Barnes E, Tositti G, Giordani MT, Grasso A, De Lalla F.

Curr Pharm Des. 2004;10(17):2111-22. Review.

PMID:
15279550
18.

Access to occupational postexposure prophylaxis for primary health care workers in rural Africa: a cross-sectional study.

De Baets AJ, Sifovo S, Pazvakavambwa IE.

Am J Infect Control. 2007 Oct;35(8):545-51.

PMID:
17936147
19.

Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.

Roux P, Fugon L, Winnock M, Salmon-Céron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group.

Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12.

PMID:
21819472
20.

Strategies to optimize HIV treatment outcomes in resource-limited settings.

Nakanjako D, Colebunders R, Coutinho AG, Kamya MR.

AIDS Rev. 2009 Oct-Dec;11(4):179-89. Review.

PMID:
19940945
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk